Benlysta 200 MG/ML autoinjectml
Ended Awarded
- Contract number
- SPE2DB26FKST8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,165
Award facts
- Contract value 100% obligated
- $6,165.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,165.36 for BENLYSTA 200 mg/ml auto-injector on October 14, 2025, with an ultimate completion date of November 4, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BENLYSTA (belimumab) is a biologic immunosuppressant medication used to treat systemic lupus erythematosus and other autoimmune conditions, representing a specialized pharmaceutical product within the federal medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders under this prime contract, demonstrating its established capability to fulfill specialized and routine pharmaceutical requirements across multiple therapeutic domains for the Department of Defense medical systems.
Quick answers
Who was awarded contract SPE2DB26FKST8?
SPE2DB26FKST8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 14, 2025.
How much is contract SPE2DB26FKST8 worth?
The government has obligated $6,165 on SPE2DB26FKST8.
Is contract SPE2DB26FKST8 an order under another contract?
Yes. SPE2DB26FKST8 is a delivery order under SPE2DB22D1002, an indefinite delivery contract.
Was contract SPE2DB26FKST8 competed?
The extent of competition for SPE2DB26FKST8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award